# Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in Breast Cancer Patients

> **NCT05326295** · — · RECRUITING · sponsor: **Hunan Cancer Hospital** · enrollment: 1000 (estimated)

## Conditions studied

- Breast Neoplasms
- Neoplastic Cells, Circulating
- Chemotherapy Effect

## Interventions

- **DIAGNOSTIC_TEST:** CTC detection

## Key facts

- **NCT ID:** NCT05326295
- **Lead sponsor:** Hunan Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-03-01
- **Primary completion:** 2028-03-01
- **Final completion:** 2029-03-01
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2022-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05326295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05326295, "Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in Breast Cancer Patients". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05326295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*